Purification of Proteins.--Mouse myeloma proteins MOPC 141 (IbG2b), MOPC 195
(IgG2b), MOPC 21 (IgG1), and S 121 (IgA) were purified by starch block electrophoresis. In the case of S 121 further purification was obtained by gel filtration on Sephadex G-200. Cohn Fraction II of normal chicken serum was exhaustively absorbed with Balb/c thymus and spleen cells to remove heterophile activity. Absorbed CGG did not bind to mouse lymphocytes when tested by indirect immunofluorescence. Bovine albumin powder, fraction V from bovine plasma was obtained from Metrix (Armour and Co., Ltd., Eastbourne, England) lot J39404 and used without further purification. Human "),-globulin was obtained by DEAE chromatography of Cohn Fraction II (obtained from the American Red Cross). Papain digestion of mouse IgG and separation of Fab and Fc fragments was performed as previously described (22) .
Aggregation of Protdns.--Myeloma proteins MOPC 141, MOPC 195
, and CGG at concentrations of 2 mg/ml in PBS were heated in a 63 ° C water bath until barely visible opalescence was obtained. For CGG the time required for aggregation was less than 1 rain, for MOPC 195 about 3 rain, and for MOPC 141 10-11 min. Alternatively, these proteins and others used in this study which did not readily form soluble aggregates upon heating were aggregated with BDB according to the method of Ishizaka (18) . It was found that by varying the relative concentrations of protein and BDB, large soluble aggregates could be obtained. BDB and heat-aggregated preparations of the same protein behaved similarly with respect to lymphocyte-binding capacity.
Aggregates were radioiodinated with m5I by a modification of the chloramine T method (23) . Specific activities ranged from 6-9/zCi//zg. Labeled aggregates were diluted to a concentration of 5 /zg/ml in 10% heat-inactivated calf serum/HBSS and were centrifuged at 3,000 rpm for 20 min immediately before use.
The extent of aggregation was evaluated by Sepharose 4B gel filtration. For covalently linked aggregates 3% polyacrylamide gel electrophoresis in SDS was also performed (8) . Polyacrylamide gels were either stained with Coomasie blue or in the case of radiolabeled proteins were fractionated on an autogel divider (Savant Instruments, Inc., Hicksville, N. Y.) and counted in an automatic gamma scintillation counter.
Binding Assay and Autoradiography.--Cells prepared as described above were resuspended in 10% heat-inactivated calf serum/HBSS. To 10-20 X 106 cells aliquoted into 5-ml polystyrene tubes was added 0.1 ml of the centrifuged radiolabeled aggregated protein solution (at 5 #g/ml), an amount calculated to be in aggregate excess. The mixture, in a total Volume of 1 ml, was incubated in a 37 ° C water bath for 1 hr. To test for inhibition of binding, the cells were first incubated for 10 rain at 37 ° C with 0.1 ml of unlabeled inhibitor protein at a concentration 500 times that of the radiolabeled test aggregate. The radiolabeled aggregate was then added and incubation at 37 ° C continued for 1 hr. The cell suspension was then diluted to 4 ml with cold medium and was centrifuged at 1,000 rpm for 10 min. The cell pellet was washed three times in medium, resuspended gently in 0.2 ml of medium, and smeared onto gelatin-coated microsope slides. Slides were allowed to air dry, fixed for 30 rain in 1% glutaraldehyde-PBS, washed for 30 rain in distilled water, and again air dried. Fixed and dried slides were dipped in NTB-2 emulsion and allowed to dry vertically. After varying periods of exposure, slides were developed and stained with Giemsa. Autoradiographs were analyzed by bright field microscopy. Between 200-300 cells were scored for the number of grains lying over or contiguous with the cell. In thymocyte and splenocyte preparations, only small mononuclear cells were scored, eliminating insofar as possible monocytes, macrophages, and polymorphonuclear cells. In macrophage preparations, only large mononuclear cells with vacuolar cytoplasm were scored. Small lymphocytes and neutrophils were excluded.
To study cell surface redistribution of bound [125I]agg-IgG, lymphocytes were incubated at 0 ° C for 1 h with 0.1 ml of the radiolabeled aggregated preparation. Unbound Ig was then removed by washing the cells three times with medium following which the cells were incubated at 37 ° C for varying periods of time. The cells were again washed and autoradiographs were made. Labeled cells were sorted into two groups: those with grains evenly situated about the cell perimeter and those with definite asymmetry of grain distribution.
To determine the percentage of SIg, + 8, + and "Null" (SIg-, ~-) lymphocytes which bound [125I]agg-141, washed spleen cells were incubated first with [125I]agg-141 for 15 rain at 37 ° C. After three washes in cold HBSS, the cells were incubated either in a direct staining procedure with fluoresceinated rabbit antimouse Ig antiserum or in an indirect procedure with anti-theta antiserum (kindly supplied by Dr. John J. Cohen) as the first layer followed by fluoresceinated antimouse Ig antiserum as the second layer. The antiserum incubations were performed at 0 ° C for 30 min in the presence of 0.03 M sodium azide. Cells were then prepared for autoradiography as described above except that absolute methanol was used as a fixative rather than glutaraidehyde. Small round cells were scored for both fluorescence and grains. The exposure times used in this experiment were chosen so that only cells with a relatively large number of agg-141 receptor sites would be scored as positive.
RESULTS

Binding of Radiolabeled Aggregated IgG to
Lymphocytes.--To determine the extent of binding of aggregated Ig to lymphocytes, cells were incubated for 1 h at 37°C with radioiodinated (6-9/zC/#g) heat-aggregated mouse IgG2b myeloma protein MOPC-141 ([125I]agg-141). This protein was selected because it readily formed soluble aggregates when heated at 63°C. Cell suspensions of mouse thymus and spleen were incubated with 0.5 tzg of pSI]agg-141 and prepared for autoradiography. A representative experiment is shown in Fig. 1 , A. After 9 days of exposure about 70 % of spleen lymphocytes contained 6 or more grains, a grain count in considerable excess of background and significantly greater than that obtained with spleen cells that had been preincubated with unlabeled aggregated MOPC-141 before the addition of the radiolabeled preparation. After a very long exposure (5 mo) autoradiographs of spleen cells showed 75 % of highly labeled small lymphocytes with more than 30 grains/cell and another 10% having 16-30 grains/cell (Fig. 1, B) . Only Thymus cells were similarly studied for their capacity to bind [12~I]agg-141 ( Fig. 2) . After a 9-day exposure, 21% of thymocytes had 6 or more grains and 31% had 3 or more grains, whereas none of the control cells had more than 2 grains/cell. After 5 mo exposure, the number of specifically labeled cells increased to 45-50 %. There was a suggestion of a bimodal distribution with one population having a peak at 6-8 grains/cell and another population with more than 20 grains/cell. The percentage of thymus cells that bound agg-141 varied considerably from one experiment to another depending on both the exposure time of the autoradiographs and the particular preparation of agg-141. In general, with exposure times of 3-4 wk, 10-20 % of thymocytes bound agg-141.
Specificity of Binding of Agg-141 to Lymphocytes.--Several parameters of the
binding of agg-IgG to lymphocytes were investigated to obtain information regarding the specificity of the interaction. First, the importance of aggregate size itself was studied. In order to study what degree of aggregation was necessary for binding, a preparation of BDB-aggregated MOPC-141 was fractionated on a Sepharose 4B column. A protein peak was obtained in the void volume followed by a broad plateau which extended from the void volume to the position of IgG monomer at which point another peak was observed. Two tubes, one close to the void volume and one close to the monomer peak, were chosen for further study. These two samples were iodinated, tested for binding to spleen and thymus lymphocytes, and analyzed for degree of aggregation by polyacrylamide electrophoresis in SDS. Table I contains the binding data together with the molecular weight information. Monomer 141 demonstrated no significant binding to either spleen or thymus lymphocytes. The fraction eluted just ahead of the monomer peak (Fr 2) had a mean aggregate size of three. Under conditions that showed unfractionated BDB agg-141 binding to 40% of splenic lymphocytes and 8% of thymocytes, the low molecular weight aggregates bound to only 5 % of spleen cells and 1% of thymocytes. Fraction 1 of the Sepharose 4B column had a mean aggregate size of about 15 and bound to 31% of spleen cells but only 2 % of thymocytes. It is obvious from these studies that the degree of binding to lymphocytes is directly proportional to aggregate size and that the optimal size is greater than 15 and probably is of a size large enough to be present in the void volume of the column, i.e., >_ 20,000,000.
Next, purified preparations of other aggregated proteins were tested for their capacity to bind to mouse lymphocytes. For this purpose a nonimmunoglobulin, preparation. This might have been due to a relatively weak capacity of IgA to bind to the IgG receptor site on lymphocytes, or alternatively, due to trace contamination of this preparation with IgG. From these data it can be concluded that lymphocyte binding of agg-141 is specific in that it is a property unique to the aggregated form of the protein and is not shared by the aggregates of several other unrelated proteins such as BSA, CGG, and IgA. It is, however, a reaction which is shared with closely related proteins such as another IgG2b protein, IgG1, and another mammalian IgG protein, HGG. Although the data are consistent with the binding site being localized to the Fc fragment, a direct demonstration of this is thus far lacking.
RECEPTORS FOR AGGREGATED IgG ON T CELLS
Effect of Temperature on the Binding of [125I]Agg-141 to Lymphocytes.--The
capacity of spleen and thymus cells to bind [l~sI]agg-141 was tested at 0 and 37°C. As shown in Table IV , except for a single experiment with spleen cells, binding at 37°C was considerably greater than at 0°C. Optimal binding was observed after 15 min incubation at 37°C, whereas no clear plateau of binding was obtained at 0°C, even after 4 h of incubation. Binding experiments were also performed at 13 and 25°C. Somewhat inconsistent results were obtained at these temperatures. In some experiments the degree of binding was equal to that observed at 37°C, whereas in others a moderate decrease in the binding capacity was observed.
Distribution of Agg-IgG Binding Sites on the Surface of Lymphocytes.--The
distribution of grains on the surface of lymphocytes that contained receptors for agg-IgG was studied, since it was apparent that under the standard conditions of incubation at 37°C, many cells had an asymmetric distribution of grains reminiscent of the "capping" phenomenon. To study the temperature requirements for this phenomenon, both thymus and spleen cells were incubated with [mI]agg-141 at 0°C for 1 h, washed, incubated at 37°C for varying lengths of times up to 120 rain, after which the cells were rapidly cooled to 0°C and prepared for autoradiography. Although few thymocytes bound [125I]agg-141 at 0°C, as shown in Table V , the proportion of labeled cells with eccentrically placed grains was high before any 37°C incubation and was not increased by warming. In contrast, capping of labeled spleen cells increased from about 20 % to over 80% by incubation at 37°C. It is obvious from these data that the majority of spleen cells undergo redistribution of receptor sites from a random distribution to a capped one following incubation at 37°C. The situation with thymocytes is more difficult to assess since an asymmetric distribution of grains was observed under all conditions of study. No conclusion can be made as to whether the observed caps on thymocytes represented a redistribution of binding sites or whether the binding sites were asymmetrically disposed on the cell surface before their binding agg-IgG. Macrophages were incubated at 0°C to prevent phagocytosis, whereas all the other cell types were incubated at 37°C. Autoradiographs were developed after varying exposure times in order to have significant numbers of grains for each cell type. Grain counts were then normalized for time of exposure and expressed as grains/cell/day of exposure. 
Comparison of Agg-IgG Binding by Different Cell Types.--To determine the
DISCUSSION
Utilizing a sensitive autoradiographic assay to detect binding of l~SI-labeled heat-aggregated mouse IgG to various cell types, we have detected receptors for agg IgG on 70-85 % of mouse spleen cells and 20-45 % of thymus. Moreover, it has been possible to demonstrate similar receptor sites on the theta-positive lymphoma cell line, L5178, as well as on spleen cells obtained from lethally irradiated FI hybrid mice infused with parental thymocytes. Simultaneous labeling of surface Ig, theta antigen, and receptor sites for agg-IgG has demonstrated that the majority of B lymphocytes possess a relatively high density of receptor sites for aggregated IgG. A subpopulation of theta-positive cells also possess relatively large numbers of receptors as does a subpopulation of SIg-, 0--, null cells. There are two aspects of our study which need to be focused upon before discussing these results in relation to previous studies. First, as shown in Fig. 3 , there is a great deal of heterogeneity in the number of agg IgG receptor sites when different cell types are compared. For instance, there is approximately a 100-fold difference in binding capacity between thymocytes and macrophages or P815 mastocytoma cells. Even within a tissue such as the spleen there is at least a 10-fold difference in receptor density when individual cells are compared. Second, besides having to prolong exposure times to detect cells with low receptor density, it was also necessary to use large sized aggregates. Our data indicate that optimal binding was obtained with aggregates in or near the exclusion volume of a Sepharose 4B column, i.e., of a size 20 million or more. This finding concurs with the data of Dickler and Kunkel (14) who found that aggregates of greater than 300S had to be used to obtain optimal binding to human B cells.
These factors--heterogeneity of numbers of receptors on different cells, importance of aggregate size, and sensitivity of the detection system--may, at least in part, explain why our results differ from those of others whose work has indicated that IgG receptor sites were limited to bone marrow derived lymphocytes. The reports of Basten et al. (12, 13) which indicated that binding of Ig was a property limited to B lymphocytes (although 2-4 % of C57/B16 thymocytes were also positive) does not permit an analysis of aggregate size since undefined ratios of antigen and antibody were used to form the aggregates assayed for in their systems. With respect to sensitivity of assay, species and tissues studied, their system was similar to that we employed. Bentwich et al. (24) used similar sized aggregates, but a different, perhaps less sensitive, test system (immunofluorescence). Also their studies were done on human peripheral blood lymphocytes, whereas ours were performed on mouse spleen and thymus. It is difficult to assess which of these several differences between laboratories may account for the higher degree of B-cell specificity of the agg IgG receptor in the Bentwich et al. study (2-4 % of T cells, as measured by their capacity to form rosettes with sheep erythrocytes, also bound agg-IgG) and the lack of such specificity in our study. The possibility that in peripheral blood the agg IgG receptor is primarily associated with B cells, whereas in the spleen it is not, is considered a real one since in a previous study on the occurrence of surface immunoglobulin and complement receptors (25) , it was found that whereas in peripheral blood the complement receptor was found almost exclusively on SIg + cells, in the spleen there was a significant population of cells that were SIg-complement receptor positive.
As mentioned above, although our results are at variance with previous reports indicating that only B cells bear receptor sites for IgG, there are other studies which support our data that lymphoid cells other than B cells also possess such a receptor. Previous studies with the theta-positive lymphoma L5178 (8) Experiments to test for the presence of aggregated IgM receptor sites in our system have not as yet been possible due to the lack of suitable aggregated IgM preparations. Work by Greenberg et al. (26, 27 ) studying antibody-dependent, cell-mediated cytotoxicity suggests that a non-B, non-T lymphoid cell with sedimentation velocity characteristics of nonphagocytic monocytes is the effector cell in this reaction. It is likely that some of the non-B non-T cells that we have detected by our aggregated IgG assay are similar to the cytotoxic cells that Greenberg describes.
The difference between the density of receptor sites on normal spleen cells as compared with spleen cells obtained from animals injected with semiallogeneic parental cells was striking. Whether this represents an increase in receptor density following activation of T cells or is merely a characteristic of any proliferating lymphocyte population has not as yet been determined, and experiments to further investigate this phenomenon are underway.
Finally, the existence of IgG receptors on some T cells accentuates the problem of evaluating the presence of small amounts of T-cell-associated Ig as a possible synthetic product of T cells. Moreover, the use of this receptor as a means of eliminating B cells from a mixed population of lymphocytes must be done with the understanding that a receptor-bearing subpopulation of non-B cells, perhaps functionally important, may also be removed. 
